These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32024723)

  • 1. Expanding U.S. Laboratory Capacity for Neisseria gonorrhoeae Antimicrobial Susceptibility Testing and Whole-Genome Sequencing through the CDC's Antibiotic Resistance Laboratory Network.
    Kersh EN; Pham CD; Papp JR; Myers R; Steece R; Kubin G; Gautom R; Nash EE; Sharpe S; Gernert KM; Schmerer M; Raphael BH; Henning T; Gaynor AM; Soge O; Schlanger K; Kirkcaldy RD; St Cyr SB; Torrone EA; Bernstein K; Weinstock H
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory Capacity for Antimicrobial Susceptibility Surveillance of Neisseria gonorrhoeae-District of Columbia, 2007-2012.
    Garrett TA; Davies-Cole J; Furness B
    Sex Transm Dis; 2015 Aug; 42(8):413-6. PubMed ID: 26165430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening the US Response to Resistant Gonorrhea: An Overview of a Multisite Program to Enhance Local Response Capacity for Antibiotic-Resistant Neisseria gonorrhoeae.
    Schlanger K; Learner ER; Pham CD; Mauk K; Golden M; Wendel KA; Amsterdam L; McNeil CJ; Johnson K; Nguyen TQ; Holderman JL; Hasty GL; St Cyr SB; Town K; Nash EE; Kirkcaldy RD;
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S97-S103. PubMed ID: 34475362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Gonococcal Antimicrobial Resistance Surveillance in Cisgender Women, Strengthening the US Response to Resistant Gonorrhea, 2018 to 2019.
    Wendel KA; Mauk K; Amsterdam L; McNeil CJ; Pfister JR; Mobley V; Mettenbrink C; Nishiyama M; Terrell E; Baldwin T; Pham CD; Nash EE; Kirkcaldy RD; Schlanger K
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S104-S110. PubMed ID: 34475358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.
    Barbee LA; St Cyr SB
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S95-S111. PubMed ID: 35416971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen years of a nationwide culture collection of Neisseria gonorrhoeae antimicrobial resistance in Portugal.
    Pinto M; Rodrigues JC; Matias R; Água-Doce I; Cordeiro D; Correia C; Gomes JP; Borrego MJ;
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1761-1770. PubMed ID: 32494956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017-2019.
    Adamson PC; Van Le H; Le HHL; Le GM; Nguyen TV; Klausner JD
    BMC Infect Dis; 2020 Nov; 20(1):809. PubMed ID: 33153450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of MALDI-TOF MS for differentiation of Neisseria gonorrhoeae isolates with dissimilar azithromycin susceptibility profiles.
    Pham CD; Pettus K; Nash EE; Liu H; St Cyr SB; Schlanger K; Papp J; Gartin J; Dorji T; Akullo K; Kersh EN;
    J Antimicrob Chemother; 2020 Nov; 75(11):3202-3208. PubMed ID: 32737509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Characterization of Emerging Bacterial Uropathogen Neisseria meningitidis, Which Was Misidentified as Neisseria gonorrhoeae by Nucleic Acid Amplification Testing.
    Sukhum KV; Jean S; Wallace M; Anderson N; Burnham CA; Dantas G
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33177123
    [No Abstract]   [Full Text] [Related]  

  • 12. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
    Sosa J; Ramirez-Arcos S; Ruben M; Li H; Llanes R; Llop A; Dillon JA
    Sex Transm Dis; 2003 May; 30(5):443-8. PubMed ID: 12916137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.
    Ryan L; Golparian D; Fennelly N; Rose L; Walsh P; Lawlor B; Mac Aogáin M; Unemo M; Crowley B
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1661-1672. PubMed ID: 29882175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988-1991. The Gonococcal Isolate Surveillance Project Study Group.
    Gorwitz RJ; Nakashima AK; Moran JS; Knapp JS
    MMWR CDC Surveill Summ; 1993 Aug; 42(3):29-39. PubMed ID: 8345839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a Neisseria gonorrhoeae Ciprofloxacin panel for an antimicrobial resistant Isolate Bank.
    Liu H; Tang K; Pham CD; Schmerer M; Kersh EN; Raphael BH
    PLoS One; 2022; 17(3):e0264149. PubMed ID: 35271599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.